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VALIDATION OF C-REACTIVE PROTEIN IN THE EARLY DIAGNOSIS OF
NEONATAL SEPSIS IN A TERTIARY CARE HOSPITAL IN KENYA
R. KUMAR, R. MUSOKE, W. M. MACHARIA and G. REVATHI
ABSTRACT
Objective: To evaluate utility of C-reactive protein (CRP) in the early diagnosis of
neonatal sepsis in a tertiary care Newborn Unit in Kenya.
Design: Cross-sectional study.
Setting: Newborn Unit, Kenyatta National Hospital.
Subjects: All neonates admitted to Newborn Unit, Kenyatta National Hospital during
the study period with suspected sepsis based on speciﬁed clinical criteria.
Results: Of the 310 infants, there were 83 episodes of proven sepsis and 94 episodes of
probable sepsis. Using the standard CRP cut-off value of 5 mg/dl, a sensitivity of 95.2%
in proven sepsis and 98.9% for probable septic episodes were noted. In proven sepsis, a
speciﬁcity of 85.3%, positive predictive value of 80.6%, and a negative predictive value
of 96.5% were noted. In probable sepsis, a speciﬁcity of 83.3%, positive predictive value
of 80.9% and a negative predictive value of 99.1% were noted. The overall accuracy in
proven sepsis was 96.5%, and in probable sepsis was noted to be 99.1%. Sub-analysis
showed a lower positive predictive value (61.5%) for early onset sepsis compared to
93% for late onset sepsis. Repeat CRP tests were done in 33 babies. Twenty two of the
29 with proven/probable infection had a ten-fold increase in CRP levels, but levels were
noted to be low or reducing in seven (24.1%) babies showing signs of improvement
clinically. Using a receiver operator characteristic curve, the optimal cut-off point for
CRP was found to be 5 mg/dl.
Conclusions: Serum CRP is an accurate indicator of neonatal sepsis, with high sensitivity,
speciﬁcity and predictive values, at the standard cut-off of 5. CRP is a better screening
test for late-onset than early-onset neonatal sepsis. The standard recommended CRP
cut -off point of 5 is appropriate for local use.
INTRODUCTION
Neonatal sepsis is a clinical syndrome characterised by
a rapid onset of systemic signs and a high morbidity
and mortality (1). In Kenya, Musoke et al (2-4) reported
a high sepsis rate with a case fatality rate of 20-42%.
Early diagnosis and treatment are essential but subtle
and non-speciﬁc clinical features and unavailability
of rapid, accurate and cost-effective laboratory tests
have made this difﬁcult. Blood culture which is the
gold standard takes 48-72 hours and in many septic
infants it may be negative (1, 5).
Normally, there is no CRP in blood serum. CRP
is secreted in increased amounts within six hours of
acute inﬂammatory stimulus, and continues to increase
several hundred-fold within 24-48 hours. After effective
treatment, levels fall rapidly within ﬁve to seven hours.
Persistently elevated CRP during antibiotic therapy
should suggest the possibility of fungal infection,

resistant organisms or development of a complication
(6-8). Several workers have evaluated this test and
reported high sensitivity and speciﬁcity. It is probably
the one test that helps in diagnosing sepsis in infants
with negative blood cultures (8-11). CRP levels can be
elevated in conditions such as meconium aspiration,
perinatal asphyxia and tissue injury. Although a result
above 1 mg/dl is usually considered high for CRP, most
infections and inﬂammations result in CRP levels above
10 mg/dl. Universally, a cut-off level of 5 mg/dl has
been accepted as the best predictor of neonatal sepsis,
with a maximum sensitivity, speciﬁcity and negative
predictive value (8,12).
CRP assays are not a routine test yet in
government run institutions in Kenya. This study
was aimed at evaluating the usefulness of CRP as
a screening test in the early diagnosis of sepsis in
neonates admitted to Kenyatta National Hospital
(KNH) with suspected sepsis.
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MATERIALS AND METHODS
A cross-sectional study was carried out in the
Newborn Unit of KNH, the national tertiary referral
and teaching hospital.
Study population and case deﬁnition: All neonates
admitted to KNH Newborn Unit during the study
period with suspected sepsis based on perinatal risk
factors or suspicious clinical ﬁndings were recruited
before ﬁrst-line (benzyl penicillin and gentamicin)
or change over to second-line antibiotics (second
or third generation cephalosporin and amikacin)
were initiated. Neonates whose parents/guardians
declined to give consent and those with history of
meconium aspiration, perinatal asphyxia, tissue
injury and severe hepatocellular involvement were
excluded. Neonates were classiﬁed into proven sepsis
(culture positive), probable sepsis (culture negative
but clinical haematological features suggestive), no
sepsis (clinical features subsided within 12 hours,
microbiological/ haematological features not
suggestive). The diagnosis at each evaluation was
categorised without consideration of CRP levels.
The required sample size was 276 using the
appropriate statistical formula for a descriptive crosssectional study. Proportion of total population with
positive culture was taken to be 30% based on the local
estimates of 6-60%. As accuracy of the study could
not be determined from other studies, sensitivity of
98% was used to calculate the sample size. The level
of statistical signiﬁcance was set at 0.03 as was the
margin of precision error.
To control for subjectivity, neonates were included
into the study, based on an agreement in the clinical
ﬁndings between attending clinician and investigator.
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(CBC), culture and CRP assays. CBC and culture were
done using standard procedures in haematology and
microbiology laboratories. CSF, stool and urine tests,
wherever indicated, was collected and processed by
standard laboratory techniques.
Radiological studies were done as indicated:
Samples for CRP were stored at -20°C and analysed as
a batch. The test principle was immuno-turbidimetric
assay. Measuring range: 0.3-24 mg/dl (0.003-0.24g/l)
Using Rodwell’s haematological scoring system, a
score of three or more, identiﬁed infants with sepsis.
Data management and statistical analysis: All data from
this study were analysed using SPSS software version
12.0. Receiver-operator characteristic (ROC) curve
was constructed to permit selection of threshold
values. Based on this cut-off point, the diagnostic
utility of CRP was determined using accuracy,
sensitivity, speciﬁcity and predictive values.
Ethical considerations: Study was undertaken after
approval by the Department of Paediatrics and Child
Health, University of Nairobi, and the Ethics and
Review Committee, KNH. Informed written consent
was also obtained from the parents/guardians of
the neonates recruited into the study following
explanation of the study protocol.
RESULTS
A total of 310 patients satisﬁed the inclusion criteria
and were recruited over a three month period (JuneSeptember 2005).

Baseline and clinical characteristics: Of the 310 infants
recruited, the male: female ratio was 1:1, with no
signiﬁcant difference in the number of term and
Laboratory methods: A total of 1.5 mls of blood was preterm neonates in the study group (P=0.062).
drawn from each infant for complete blood count Factors associated with sepsis occurred with similar
frequency in both terms and preterms.
Table 1
Baseline characteristics of study population associated with patient category
Variable

Patient category
Proven sepsis
(n=83)

Median gestational age (weeks) 34 (28-40)*

Total

Probable sepsis
(n=94)

No sepsis
(n=133)

(n=310)

34 (28-40)*

38 (28-40)*

34 (28-40)*

P-value

0.004

Mean birth weight (grams)

2.13 (SD=0.767) 2.28 (SD=0.878)

2.38 (SD=0.821) 2.23 (SD=0.822) 0.002

Median postnatal age (days)

4 (1-35)*

3 (1-46)*

1 (1-55)*

2 (1-55)*

No prior

14 (16.9)

18 (19.1)

32 (24.0)

64 (20.6)

69 (83.1)

76 (80.9)

101 (76)

246 (79.3)

0.408

antibiotic use
Recruitment
No. (%)
Failed response
to 1st line
treatment
* Range shown in brackets, SD = Standard Deviation

0.000
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As shown in Table 1, when compared with infants
with no sepsis, those with sepsis had a signiﬁcantly
lower mean birth weight (P-value = 0.002) and
median gestational age (P -value = 0.004). A signiﬁcant
difference (P-value= 0.000) was noted in the sepsis
rate among neonates recruited before ﬁrst-line and
second-line antibiotics, with proven sepsis being
more frequent in late-onset episodes (attack rate 40%)
compared to early-onset episodes (attack rate 16%).
Probable sepsis was diagnosed in 21% of early-onset
episodes and 42% of late-onset episodes.
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Correlation of diagnosis and serum CRP levels: CRP values
were compared in septic, suspected septic and nonseptic groups at the standard cut-off of 5mg/l. Test
was considered to be positive when CRP was >5mg/l.
Proven or probable sepsis was strongly correlated
with elevated CRP levels. The calculated sensitivities
and speciﬁcities of each testing strategy are shown in
the Tables 3 and 4. To assess the ability of abnormal
and normal CRP levels to identify the presence or
absence of infection, respectively, the positive and

Table 2
Frequency distribution of aetiological organisms cultured from blood and CSF
Gram-negative organism
Enterobacter agglomerans
Citrobacter
Klebsiella pneumonia
Acinetobacter spp
Escherichia coli
Unidentiﬁed gram-negative bacilli
Salmonella typhi

(%)
26.5
12.3
13.4
7.8
6.7
4.5
1.1

Gram-positive organism
Coagulase negative staph.
Staphylococcus aureus
Enterococcus

Overall in-hospital mortality was higher in
patients with sepsis (deﬁnite and probable), compared
with no sepsis. Sepsis rate was noted to be predominant
in neonates older than two days. There was no
signiﬁcant difference in the rate of sepsis among males
and females in the different postnatal groups.
Organisms were isolated from 83 blood cultures
and two CSF cultures. As shown in Table 2, overall
72.7% were gram negative organisms, 22.4% were
gram positive organisms and 4.5% of the isolates
were Candida.

(%)
13.4
4.5
4.5

Fungus
Candida

(%)
4.5

negative predictive values for each testing strategy
were calculated.
A high sensitivity of 95.2% in proven septic
episodes and 98.9% for probable septic episodes were
noted. In proven sepsis, a speciﬁcity of 85.3%, a PPV
of 80.6% and a NPV of 96.5% were noted. In probable
infection, a speciﬁcity of 83.3%, PPV of 80.9% and a
NPV of 99.1% were noted. The overall accuracy in
proven sepsis was 96.5%, and in probable sepsis was
noted to be 99.1% (Tables 3 and 4).

Table 3
Diagnostic utility of C-Reactive protein in babies with proven sepsis
Test result
Positive
Negative
Total

Proven sepsis
79
4
83

Sensitivity= 79/83= 95.2%
Speciﬁcity= 110/129= 85.3%
Positive predictive value= 79/98= 80.6%
Negative predictive value= 110/114= 96.5%
Overall accuracy= 189/212= 89.1%

No sepsis
19
110
129

Total
98
114
212
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Table 4
Diagnostic utility of C-Reactive protein in babies with
probable sepsis

Table 6
Diagnostic utility of C-Reactive protein in babies with
probable sepsis

Test result

Test result

Positive
Negative
Total

Probable
sepsis
93
1
94

No sepsis

Total

22
110
132

115
111
226

Positive
Negative
Total

Probable
sepsis
37
0
37

No sepsis

Total

18
85
103

55
85
140

Sensitivity= 93/94= 98.9%
Speciﬁcity= 110/132= 83.3%
Positive predictive value= 93/115= 80.9%
Negative predictive value= 110/111= 99.1 %
Overall accuracy= 203/226= 89.8%

Sensitivity= 37/37= 100%
Speciﬁcity= 85/103= 82.5%
Positive predictive value= 37/55= 67.3%
Negative predictive value= 85/85= 100%
Overall accuracy= 122/140= 87.1%

As shown in Tables 5-8, a further sub-analysis
was done in the study patients, classifying them into
early-onset and late-onset septic categories. Serum
CRP levels were noted to be >5mg/l in babies with
proven infection, 88.9% in early and 98.2% in lateonset episodes. In probable infection, high CRP levels
were noted in all patients in the early-onset and
98.2% patients in the late-onset episodes. Sensitivity
and speciﬁcity of CRP measurements for late-onset
proven infections was higher than for early-onset
proven episodes. The positive predictive value was
low in early onset episodes, compared to the late
onset episodes where the positive predictive values
were more than 93%. Negative predictive value was
high in both early and late-onset episodes. Overall
accuracy was higher in late-onset than in early-onset
episodes.

Late-onset episodes

Early-onset episodes:
Table 5
Diagnostic utility of C-Reactive protein in babies with
proven sepsis
Test result
Positive
Negative
Total

Proven
sepsis
24
3
127

No sepsis

Total

15
85
100

39
88
127

Sensitivity= 24/27= 88.9%
Speciﬁcity= 85/100= 85%
Positive predictive value= 24/39= 61.5%
Negative predictive value= 85/88= 96.6%
Overall accuracy= 109/127= 85.8%

Table 7
Diagnostic utility of C-Reactive protein in babies with
proven sepsis
Test result
Positive
Negative
Total

Proven sepsis No sepsis
55
4
1
25
56
29

Total
59
26
85

Sensitivity= 55/56= 98.2%
Speciﬁcity= 25/29= 86.2%
Positive predictive value= 55/59= 93.2%
Negative predictive value= 25/26= 96.1%
Overall accuracy= 80/85= 94.1%
Table 8
Diagnostic utility of C-Reactive protein in babies with
probable sepsis
Test result Probable sepsis
Positive
56
Negative
1
Total
57

No sepsis Total
4
60
25
26
29
86

Sensitivity= 56/57= 98.2%
Speciﬁcity= 25/29= 86.2%
Positive predictive value= 56/60= 93.3%
Negative predictive value= 25/26= 96.1%
Overall accuracy= 81/86= 94.2%
Repeat CRP tests were done on 33 infants with
suspected sepsis, 48 hours after the initial sampling;
a ten fold increase in serum CRP levels was noted in
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babies with proven/probable infection compared
to initial CRP values. Neonates with infections not
responding to antibiotic treatment had a persistent
rise in CRP levels. The second CRP levels were noted
to be low in babies showing signs of improvement
clinically. One infected patient in whom the CRP did
not exceed the normal range showed a dramatic 200fold rise from 0.015 mg/l on day one, to 3.02 mg/1
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after 48 hours. Serum CRP levels remained more or
less the same in the non-septic category (Figure 1).
Using the ROC curve, the point on the curve that
lies closest to the upper left corner, best deﬁnes the cutoff that can be used in order to determine the utility of
CRP as seen in the Figure 2. When computed with SPSS
version 12.0, this corresponds to a CRP level of 5 mg/dl,
in-keeping with the standard recommended cut-off.

Figure 1
Comparison of baseline and 24- 48 hours CRP levels among antibiotic responders and non-responders

Test Serial no.
Figure 2
Receiver operating characteristic (ROC) curve for C-Reactive protein
ROC for probable and proven sepsis
Proven sepsis

Sensitivity

Probable sepsis

-0. 2

0

0.2

0.4

0.6

1 - Speciﬁcity

0.8

1

1.2
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DISCUSSION

Bacterial sepsis was conﬁrmed in 26.8% of the study
neonates (83 of 310 episodes in neonates clinically
suspected to have sepsis), confirming the low
sensitivity of blood body ﬂuid cultures, but used as
the gold-standard due to lack of other more accurate
diagnostic tools. Out of the total, 30.3% infants (94
of 310 episodes) were classiﬁed as having probable
sepsis, comprising a difﬁcult diagnostic group which
could not be ignored, as fatal infection has been
reported in the presence of negative blood cultures.
In the majority of these infants, intrapartum or
postpartum antibiotic therapy probably inﬂuenced
culture results (13).
Serum concentrations of CRP increase several
hundredfold in response to infection, but recognition
that a delay of at least six to eight hours is intrinsic to
the cascade of events leading to elevation of serum
CRP levels led to appropriate criticisms of this test
as having insufﬁcient sensitivity to guide therapy
either by reliably diagnosing or excluding bacterial
infection (14). Philip et al (15) suggested that serial
normal levels are useful for identiﬁcation of infants
who do not have bacterial infection. Gerdes and Polin
(9) reported high sensitivity (93%) and NPV (99%)
for CRP levels determined by a latex agglutination
method at the time of evaluation and 12 to 24 hours
later. Pourcyrous and Boda (16) found that two
levels measured over the ﬁrst three days in neonates
with infection had a high NPV, and suggested that
the utility of CRP levels might be optimised by
obtaining serial levels at 12-hour intervals in the
ﬁrst 24 to 36 hours of illness. Philip and Hewitt (17)
reported no recurrence of infection within 7 days of
discontinuation of antibiotics based on three normal
CRP determinations within 48 hours and negative
cultures, in low birth weight infants at risk for earlyonset infection. Based on these data, determinations
of serum CRP levels were incorporated into our
diagnostic approach to suspected neonatal sepsis.
The sensitivity of CRP was found to be 88.9%
for early onset proven sepsis and 98.2% for late-onset
proven sepsis. Despite this high sensitivity, one would
have desired an even higher sensitivity for early-onset
episodes such that very few or none of the cases would
be missed in neonates with such a life-threatening
illness. The lower scores for sensitivity in early-onset
episodes reﬂect the lag period between the onset of
infection and production of sufﬁcient CRP to exceed
the normal range. The higher prevalence of elevated
CRP levels in late-onset episodes is not unexpected,
because their infections had been present for sufﬁcient
time to produce persistent elevation in serum CRP
levels. The study showed the CRP to have a speciﬁcity
of 82.5% for early onset episodes and 86.2% for late
onset episodes. The speciﬁcity of CRP was found
to be lower than the 100% found by Wasunna et al
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(18). The low speciﬁcity found in our study could be
attributed to the inﬂuence of various non-infectious
neonatal conditions (meconium aspiration, perinatal
asphyxia, tissue injury). Studies done at KNH have
shown unreliability of Apgar Scores for babies born
at various health facilities (19); this could also have
inﬂuenced our study and led to recruitment of babies
with perinatal asphyxia. Many of these conditions,
however, are predisposing factors for neonatal sepsis
and therefore difﬁcult to control for in such a study.
Culture negative sepsis due to anaerobic organisms
and viruses that were not tested for in our study
may also have resulted in high false positive rate and
therefore a low speciﬁcity.
Intrapartum maternal exposure to antimicrobial
agents may also have contributed to the low speciﬁcity,
by increasing the number of culture-negative but
test-positive cases; this factor was not controlled for
in the study. Neonates born to mothers who have
received intrapartum antibiotics are still at risk for
sepsis and need to be evaluated and treated for sepsis
as appropriate, and this was done in this study.
However, neonates were recruited into the study only
before initiation of ﬁrst-line or change to second-line
therapy, in an attempt to minimise the inﬂuence of
prior antimicrobial exposure on culture yield.
The CRP values had a positive predictive value
of 61.5% in early-onset sepsis and 93.2% for late-onset
sepsis. The lower scores for positive predictive values
reﬂect the lag period between the onset of infection
and production of sufﬁcient CRP to exceed the normal
range. The negative predictive values in this study
were found to be 96.6% for early-onset sepsis and
96.1% for late-onset sepsis, which is reasonably high
and consistent with the high sensitivity and is also
in keeping with studies done elsewhere.
In attempting to diagnose a serious condition such
as neonatal sepsis, a condition that is life threatening
and yet treatable, a diagnostic test with maximal
sensitivity and speciﬁcity is desirable. Elevated CRP
levels strongly correlated with infection for both
early-onset and late-onset episodes, whether single
or serial levels were considered and independent of
whether probable cases were grouped with proven
cases, or considered separately. The diagnostic utility
of CRP was compared in early-onset and late-onset
episodes. The overall accuracy was slightly higher
for the diagnosis of late-onset sepsis than early-onset
sepsis.
A receiver operating characteristic (ROC) curve
was plotted to determine the best cut-off value for
CRP. A cut-off value of ﬁve was found to give the
best compromise between the true positive rate
(sensitivity) and the false positive rate (1- speciﬁcity).
In a life-threatening and rapidly progressive condition
such as neonatal sepsis, the need for a very sensitive
test justiﬁed the use of 5mg/dl as the cut-off, inkeeping with standard universal cut-off.

EAST AFRICAN MEDICAL JOURNAL

June 2010

Is there any role of CRP in clinical-decision
making? A major role for serum CRP measurement
lies in its capacity to exclude the diagnosis of sepsis
if CRP remains normal. The converse is also true and
a raised CRP should greatly enhance the suspicion
of infection. CRP can therefore be used to initiate
treatment even in the absence of other evidence. CRP
was shown to fall in response to effective antimicrobial
therapy and a rapid, sensitive assay such as we have
used should be valuable for objective monitoring of
the success and duration of treatment.
Cost effectiveness was not part of the current
study but in a study done elsewhere, the total costs of
oral and parental antibiotics were compared between
two groups: those subjected to advance testing (CRP
and WBC counts at initial evaluation) and those who
were not. A 30% reduction in costs was achieved
with advanced testing (20). In the current study, the
cost of the tests was US dollars 2.7 per test. This cost
is certainly much less than what would be spent in
the treatment of a baby when one cannot exclude
infection. In addition the test takes only 15 minutes
and does not require professional expertise. Future
development of a non-isotopic counterpart of the
present assay should make the beneﬁts of CRP testing
in neonatal practice available as a side-room test in
paediatric units generally.

4.

The limitation of the study was that serial serum
CRP assays were difﬁcult to perform due to ﬁnancial
constraints for CRP assays.

13.

In conclusions, serum CRP is an accurate indicator
of neonatal sepsis. CRP is a better screening test
for late-onset than early onset neonatal sepsis. The
standard recommended CRP cut-off point of 5mg/l
is appropriate for local use. All babies with suspected
sepsis should be screened. If initial level is low, repeat
CRP test done after 8-12 hours will help in indicating
which babies require antibiotic therapy.

5.
6.

7.

8.

9.
10.

11.
12.

14.
15.
16.
17.
18.
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